Associations between circulating amino acids and metabolic dysfunction‐associated steatotic liver disease in individuals living with severe obesity
Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD) describes liver diseases caused by the accumulation of triglycerides in hepatocytes (steatosis) as well as the resulting inflammation and fibrosis. Previous studies have demonstrated that accumulation of fat in visceral adipos...
Saved in:
| Main Authors: | Ina Maltais‐Payette, Jérôme Bourgault, Marie‐Frédérique Gauthier, Laurent Biertho, Simon Marceau, François Julien, Patricia L. Mitchell, Christian Couture, Francis Brière, Jacques Corbeil, Benoit J. Arsenault, André Tchernof |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-02-01
|
| Series: | Physiological Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.14814/phy2.70171 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High-throughput measurement of adipocyte size with open-source software using whole-slide adipose tissue images
by: Alan Ramalho, et al.
Published: (2025-12-01) -
Circulating Amino Acid Changes Three Years After Bariatric Surgery
by: Ina Maltais-Payette, et al.
Published: (2025-04-01) -
Prevalence of steatotic liver disease and associated fibrosis in the general population: An epidemiological survey: Letter to the editor on “Epidemiology of metabolic dysfunction-associated steatotic liver disease”
by: Lin Guan, et al.
Published: (2025-04-01) -
Applicability of Statins in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
by: Thaninee Prasoppokakorn
Published: (2025-01-01) -
Pathogenic aspects of fructose consumption in metabolic dysfunction-associated steatotic liver disease (MASLD): A narrative review
by: Katharina Burger, et al.
Published: (2025-06-01)